Loading...
Loading...
PETVW| Name | Value |
|---|---|
| Revenues | 207.4K |
| Cost of Revenue | 140.9K |
| Gross Profit | 66.5K |
| Operating Expense | 3,010.8K |
| Operating I/L | -2,944.3K |
| Other Income/Expense | -716.8K |
| Interest Income | 0.0K |
| Pretax | -3,661.2K |
| Income Tax Expense | 2.4K |
| Net Income/Loss | -3,661.2K |
PetVivo Holdings, Inc. is a veterinary biotech and biomedical device company specializing in licensing and commercializing medical devices and biomaterials for treating afflictions and diseases in animals. Its flagship product, Kush, is a veterinarian-administered joint injection designed to address osteoarthritis and lameness in dogs and horses. The company's revenue is generated through the sale and licensing of these medical devices and biomaterials, with a pipeline of 17 therapeutic devices for veterinary and human clinical applications.
